{"id":"omega-3-fatty-acid-capsules","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Gastrointestinal upset (nausea, dyspepsia)"},{"rate":"5-10","effect":"Fish aftertaste"},{"rate":"<1","effect":"Bleeding or bruising (at high doses)"},{"rate":"1-5","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL4298065","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Omega-3 polyunsaturated fatty acids (EPA and DHA) competitively inhibit arachidonic acid metabolism, reducing production of pro-inflammatory eicosanoids and increasing anti-inflammatory mediators. They also lower hepatic triglyceride synthesis and improve endothelial function, contributing to cardiovascular protection and reduced atherosclerotic risk.","oneSentence":"Omega-3 fatty acids reduce triglycerides and modulate inflammatory pathways to support cardiovascular and metabolic health.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:58:13.081Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertriglyceridemia"},{"name":"Cardiovascular disease prevention"},{"name":"Inflammatory conditions"}]},"trialDetails":[{"nctId":"NCT07111065","phase":"PHASE2","title":"FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)","status":"NOT_YET_RECRUITING","sponsor":"National Institute of Environmental Health Sciences (NIEHS)","startDate":"2026-04-01","conditions":"Dermatomyositis (DM), Juvenile Dermatomyositis (JDM)","enrollment":300},{"nctId":"NCT00536185","phase":"NA","title":"Heart & Health Study","status":"COMPLETED","sponsor":"USDA, Western Human Nutrition Research Center","startDate":"2006-12","conditions":"Heart Disease","enrollment":166},{"nctId":"NCT03911414","phase":"PHASE4","title":"A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-06-18","conditions":"Mood Disturbance, Mood Disorders, Natural Supplements","enrollment":27},{"nctId":"NCT07480707","phase":"NA","title":"Can People Achieve a Target Omega-3 Index by Following a Personalized Omega-3 Dosing Regimen?","status":"NOT_YET_RECRUITING","sponsor":"Fatty Acid Research Institute","startDate":"2026-05-01","conditions":"Omega-3 Fatty Acids","enrollment":48},{"nctId":"NCT07391254","phase":"NA","title":"Omega-3 Supplementation and Mental Health in College Students","status":"COMPLETED","sponsor":"University of Colorado, Colorado Springs","startDate":"2024-08-29","conditions":"Mental Health, Vitamin D","enrollment":103},{"nctId":"NCT06434948","phase":"PHASE2","title":"The Effect of Omega 3 Supplementation on Postoperative Delirium in Elderly Patients Undergoing Major Cardiac Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"University of Missouri-Columbia","startDate":"2026-03-03","conditions":"Postoperative Delirium","enrollment":90},{"nctId":"NCT06123286","phase":"EARLY_PHASE1","title":"Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms","status":"RECRUITING","sponsor":"Philip Chang","startDate":"2025-09-12","conditions":"Breast Cancer, Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS), Joint Pain","enrollment":30},{"nctId":"NCT07439601","phase":"NA","title":"Long-Term Omega-3 and Omega-3 Index >8%: Effects on Physiological Recovery","status":"NOT_YET_RECRUITING","sponsor":"St. Mary's University, Twickenham","startDate":"2026-02-28","conditions":"Focus on Omega 3 Index on Recovery","enrollment":46},{"nctId":"NCT03598309","phase":"PHASE2","title":"Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers","status":"ACTIVE_NOT_RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2019-06-05","conditions":"Lung Diseases, Lung Cancer, Protection Against","enrollment":19},{"nctId":"NCT07439744","phase":"NA","title":"NUTRIMOOD-Inflammation and Depressive Comorbidity in Obesity: Modulation by Omega-3 Polyunsaturated Fatty Acids Status","status":"RECRUITING","sponsor":"National Science and Technology Council, Taiwan","startDate":"2025-03-01","conditions":"Obese Adults, MDD","enrollment":50},{"nctId":"NCT00682318","phase":"NA","title":"Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Carsten Skarke, MD","startDate":"2008-05","conditions":"Healthy","enrollment":40},{"nctId":"NCT06802068","phase":"NA","title":"Change in Omega 3 Index in Healthy Adults With OmeGo or a Standard Omega-3 Oil Supplement","status":"COMPLETED","sponsor":"Hofseth Biocare ASA","startDate":"2025-02-18","conditions":"Supplementation in Healthy Adults to Assess Impact on Omega 3 Index and Cardiometabolic Health","enrollment":96},{"nctId":"NCT06991296","phase":"NA","title":"Concentration of n-3 PUFA Monohydroxylated Derivatives in Adults With Obesity After n-3 PUFA Supplementation.","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2025-06-02","conditions":"Obesity","enrollment":33},{"nctId":"NCT04810546","phase":"NA","title":"Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2022-02-01","conditions":"Iron-deficiency, Pregnancy Anemia, Obesity","enrollment":23},{"nctId":"NCT05774665","phase":"PHASE2","title":"Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2025-01-30","conditions":"Treatment Resistant Depression, Inflammation, Overweight","enrollment":80},{"nctId":"NCT01747447","phase":"NA","title":"VITamin D and OmegA-3 TriaL: Effects on Bone Structure and Architecture (VITAL)","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2012-08","conditions":"Bone Density, Body Composition, Bone Health","enrollment":771},{"nctId":"NCT07393399","phase":"NA","title":"Omega-3 Supplementation in Systemic Lupus Erythematosus","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo","startDate":"2026-07","conditions":"Lupus Erythematosus, Systemic","enrollment":80},{"nctId":"NCT01704859","phase":"NA","title":"VITamin D and OmegA-3 TriaL (VITAL): Fractures, Vitamin D and Genetic Markers","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2018-06-01","conditions":"Fractures","enrollment":25871},{"nctId":"NCT04573946","phase":"NA","title":"VITamin D and OmegA-3 TriaL: Interrelationship of Vitamin D and Vitamin K on Bone (VITAL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2019-07-01","conditions":"Bone Density, Bone Health, Fractures","enrollment":25871},{"nctId":"NCT07352618","phase":"NA","title":"\"Effect of Omega-3 Supplementation as Add on Therapy on Glycemic Control and Lipid Profile in Type2 Diabetes Mellitus.\"","status":"ENROLLING_BY_INVITATION","sponsor":"Bangladesh Medical University","startDate":"2026-01","conditions":"Type2 Diabetes Mellitus","enrollment":66},{"nctId":"NCT07346703","phase":"NA","title":"Effects of DHA in Patients With Multiple Sclerosis","status":"ENROLLING_BY_INVITATION","sponsor":"Francisco Javier Martínez Noguera","startDate":"2026-01","conditions":"Multiple Sclerosis, Performance Enhancement, Supplemental Nutrition Assistance Program Education","enrollment":100},{"nctId":"NCT07288619","phase":"NA","title":"Therapeutic Efficacy of Nutritional Supplementation in Cachexia Associated With Chronic Pulmonary Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Safeer Khan","startDate":"2025-10-15","conditions":"Chronic Obstructive Pulmonary Disease (COPD), Cachexia","enrollment":45},{"nctId":"NCT07034794","phase":"NA","title":"A Clinical Trial to Examine Lysoveta on Cognitive Function in Healthy Adults With Self-perceived Memory Problems","status":"RECRUITING","sponsor":"Aker BioMarine Human Ingredients AS","startDate":"2025-12-06","conditions":"Healthy, Memory Problems","enrollment":138},{"nctId":"NCT05465252","phase":"NA","title":"Effect of Omega-3 Fatty Acid Supplementation on Dry-AMD Progression","status":"RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2025-10-17","conditions":"Age-Related Macular Degeneration","enrollment":24},{"nctId":"NCT07312435","phase":"NA","title":"B-vitamins and Omega-3 Fatty Acids and Biomarkers of Brain Atrophy.","status":"RECRUITING","sponsor":"University of Oslo","startDate":"2025-09-01","conditions":"Dementia, Cognitive Function","enrollment":96},{"nctId":"NCT01343342","phase":"NA","title":"Genes, Omega-3 Fatty Acids and Cardiovascular Disease Risk Factors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Laval University","startDate":"2009-10","conditions":"Cardiovascular Disease","enrollment":200},{"nctId":"NCT03753334","phase":"PHASE2","title":"Effects of EPA in Men With Biochemical Recurrence or Progression of Prostate Cancer.","status":"ACTIVE_NOT_RECRUITING","sponsor":"CHU de Quebec-Universite Laval","startDate":"2017-07-10","conditions":"Prostate Cancer","enrollment":39},{"nctId":"NCT06933095","phase":"NA","title":"Optimizing CNS DHA Delivery in Elderly Adults at Risk for Dementia","status":"RECRUITING","sponsor":"University of Cincinnati","startDate":"2024-09-15","conditions":"Eldery People, Cognitive Decline, Memory Decline","enrollment":153},{"nctId":"NCT07226414","phase":"NA","title":"Prenatal Study in Healthy Pregnant Women","status":"RECRUITING","sponsor":"Perelel Inc.","startDate":"2025-12-01","conditions":"Pregnancy","enrollment":40},{"nctId":"NCT01653678","phase":"NA","title":"Vitamin D and Omega-3 Hypertension Trial (VITAL Hypertension)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2011-11","conditions":"Hypertension","enrollment":25875},{"nctId":"NCT07289919","phase":"NA","title":"Exploring Sustainable Alternatives to Marine Oils With Echium and Ahiflower Oils","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Sao Paulo","startDate":"2025-05-26","conditions":"Cardiovascular (CV) Risk, Atheroscleroses, Inflamation","enrollment":15},{"nctId":"NCT04417595","phase":"PHASE2","title":"Omega-3 Fatty Acids for Smoking Cessation in Pregnancy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Vanderbilt University Medical Center","startDate":"2020-11-10","conditions":"Preterm Labor, Tobacco Use Disorder","enrollment":400},{"nctId":"NCT06695910","phase":"PHASE4","title":"Modulation of the Brain Fog Scale by Eicosapentaenoic Acid Monoglycerides (MAG-EPA).","status":"RECRUITING","sponsor":"Samuel Fortin","startDate":"2024-11-06","conditions":"Brain Fog, Cognitive Health","enrollment":48},{"nctId":"NCT01696435","phase":"NA","title":"VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"Depression, Depressive Symptoms, Mood","enrollment":18353},{"nctId":"NCT07038252","phase":"NA","title":"The Effect of Oral SPM Supplementation on INflammation-induced Vascular Ageing in Obese Hypertensive Patients","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-11-26","conditions":"Hypertension, Obesity","enrollment":50},{"nctId":"NCT07255326","phase":"NA","title":"Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes","status":"RECRUITING","sponsor":"University of Faisalabad","startDate":"2025-10-01","conditions":"Diabetic Retinopathy, Type 1 Diabetes, Omega 3 Fatty Acids","enrollment":80},{"nctId":"NCT07241377","phase":"PHASE3","title":"A Study in Healthy Adults to Compare the Bioavailability of EPA + DHA From Two Microalgal Sources to One Fish Source and Placebo","status":"RECRUITING","sponsor":"RDC Clinical Pty Ltd","startDate":"2025-10-27","conditions":"Absorption of Omega-3, Omega-3 Supplementation, Healthy Participants","enrollment":120},{"nctId":"NCT01632761","phase":"NA","title":"Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2012-11","conditions":"Anemia","enrollment":2000},{"nctId":"NCT02333435","phase":"PHASE2","title":"Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life","status":"ACTIVE_NOT_RECRUITING","sponsor":"CHU de Quebec-Universite Laval","startDate":"2015-02-12","conditions":"Prostate Cancer","enrollment":130},{"nctId":"NCT06233825","phase":"NA","title":"Nutritional Intervention to Enhance Recovery After Arthroscopic Knee Surgery in Adults","status":"COMPLETED","sponsor":"Dr. Chris McGlory, PhD","startDate":"2024-02-01","conditions":"Anterior Cruciate Ligament Reconstruction, Muscular Atrophy","enrollment":30},{"nctId":"NCT07237113","phase":"NA","title":"Muscle Recovery After Omega-3 Supplementation","status":"COMPLETED","sponsor":"Instituto de Ciencias de la Salud, Universidad de O'Higgins","startDate":"2021-09-01","conditions":"Damage Muscle","enrollment":30},{"nctId":"NCT06629103","phase":"PHASE4","title":"A Study in Healthy Subjects to Compare the Bioavailability of EPA + DHA","status":"ACTIVE_NOT_RECRUITING","sponsor":"RDC Clinical Pty Ltd","startDate":"2025-08-06","conditions":"Optimal Absorption of Omega-3, Healthy","enrollment":120},{"nctId":"NCT06055894","phase":"NA","title":"A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-09-20","conditions":"Multiple Myeloma, Smoldering, Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance","enrollment":200},{"nctId":"NCT01169259","phase":"PHASE3","title":"Vitamin D and Omega-3 Trial (VITAL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"Cancer, Cardiovascular Disease","enrollment":25871},{"nctId":"NCT02178410","phase":"PHASE3","title":"VITAL Rhythm Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2012-10","conditions":"Cardiovascular Disease","enrollment":25119},{"nctId":"NCT06294067","phase":"PHASE1","title":"A Dose Response Investigation of Docosahexaenoic Acid (DHA)","status":"COMPLETED","sponsor":"University of Toronto","startDate":"2024-02-26","conditions":"Nutrition, Healthy","enrollment":72},{"nctId":"NCT06560255","phase":"PHASE3","title":"Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma","status":"RECRUITING","sponsor":"Professor Klaus Bønnelykke","startDate":"2024-12-20","conditions":"Asthma, Respiratory Tract Infections, Gastrointestinal Infection","enrollment":2000},{"nctId":"NCT05137132","phase":"NA","title":"Unrefined Salmon Oil as Dietary Supplement in Adult Asthmatics","status":"COMPLETED","sponsor":"Hofseth Biocare ASA","startDate":"2022-04-01","conditions":"Asthma","enrollment":70},{"nctId":"NCT05130294","phase":"NA","title":"Unrefined Salmon Oil as Dietary Supplement in Patient With Chronic Obstructive Pulmonary Disease","status":"WITHDRAWN","sponsor":"Hofseth Biocare ASA","startDate":"2025-07","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":""},{"nctId":"NCT01758081","phase":"NA","title":"Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 (VITAL Infection)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"Infections, Human Cathelicidin Antimicrobial Peptide (hCAP-18)","enrollment":25874},{"nctId":"NCT06538324","phase":"NA","title":"Response to an Intervention With Omega-3 (RIO - Study)","status":"COMPLETED","sponsor":"Universidad San Sebastián","startDate":"2024-07-30","conditions":"Overweight, Hypertriglyceridemia","enrollment":40},{"nctId":"NCT04553705","phase":"PHASE2, PHASE3","title":"Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2020-09-20","conditions":"Covid19, Immunodeficiency","enrollment":150},{"nctId":"NCT04152291","phase":"NA","title":"The Effect of E-EPA on Circulating LDL and Plasma Lipid Metabolism","status":"COMPLETED","sponsor":"Wihuri Research Institute","startDate":"2019-11-12","conditions":"Atherosclerosis, Low-density Lipoproteins Aggregation Susceptibility, Low-density Lipoprotein Lipid Composition","enrollment":68},{"nctId":"NCT02295059","phase":"NA","title":"Omega 3 Fatty Acids and ERPR(-)HER2(+/-) Breast Cancer Prevention","status":"ACTIVE_NOT_RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2017-08-09","conditions":"Breast Cancer","enrollment":80},{"nctId":"NCT07157241","phase":"NA","title":"Effect of Omega-3 Supplements on Stress, Anxiety, Depression, Memory and Sleep Quality Among Saudis","status":"COMPLETED","sponsor":"Umm Al-Qura University","startDate":"2022-02-27","conditions":"Healthy Adults, Anxiety, Depression","enrollment":64},{"nctId":"NCT07136519","phase":"PHASE2","title":"Toripalimab, Induction Chemotherapy, Radiation Therapy With Omega-3 for Locally Advanced Nasopharyngeal Carcinoma","status":"NOT_YET_RECRUITING","sponsor":"Affiliated Hospital of Guangdong Medical University","startDate":"2025-08-22","conditions":"Nasopharyngeal Carcinoma (NPC)","enrollment":30},{"nctId":"NCT05802797","phase":"EARLY_PHASE1","title":"Bioavailability and Pharmacodynamics of EPA and DHA From Fortified Soymilk and Capsules","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2023-04-03","conditions":"Healthy Diet","enrollment":24},{"nctId":"NCT07133477","phase":"NA","title":"A Study to Evaluate the Effect of Fish Oil Concentrate on Skin Function","status":"RECRUITING","sponsor":"Epax Norway AS","startDate":"2025-04-30","conditions":"Skin Health","enrollment":90},{"nctId":"NCT07134140","phase":"NA","title":"Omega-3 Fatty Acids in Muscle Function and Health","status":"NOT_YET_RECRUITING","sponsor":"European University Cyprus","startDate":"2025-09","conditions":"Healthy","enrollment":32},{"nctId":"NCT07127068","phase":"NA","title":"Investigation of the Effects of Omega-3 Supplementation in Chronic Kidney Disease Patients Diagnosed With Coronary Artery Disease and Dyslipidemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Beykent","startDate":"2024-06-01","conditions":"Omega 3 Fatty Acids, Coronary Arterial Disease (CAD), Chronic Kidney Disease(CKD)","enrollment":60},{"nctId":"NCT06614374","phase":"NA","title":"Fish Oil for Cognitive Function, Sleep Quality, and Bone Density","status":"COMPLETED","sponsor":"Jingjing Jiao","startDate":"2020-10-10","conditions":"Cognitive Decline, Sleep, Bone Mineral Density","enrollment":415},{"nctId":"NCT07118059","phase":"PHASE2","title":"Effects of Adjunct Omega-3 Long Chain Polyunsaturated Fatty Acids in Pulmonary Tuberculosis Patient: an Early Bactericidal Activity and Inflammatory Trial","status":"NOT_YET_RECRUITING","sponsor":"North-West University, South Africa","startDate":"2025-08","conditions":"Tuberculosis, Inflammation Biomarkers, Liver Function Tests","enrollment":40},{"nctId":"NCT07107087","phase":"NA","title":"A Cluster Randomised Controlled Trial of a Multimodal Integrated Intervention for Kidney Cachexia","status":"NOT_YET_RECRUITING","sponsor":"Queen's University, Belfast","startDate":"2025-08-01","conditions":"Cachexia, CKD","enrollment":40},{"nctId":"NCT02348073","phase":"PHASE3","title":"Efficacy of Phosphatidylserine Enriched With n-3 PUFA Supplementation on ADHD in Children With Epilepsy","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2015-03","conditions":"Attention Deficit Disorder With Hyperactivity, ADHD Inattention or Mixed Type, Epilepsy","enrollment":77},{"nctId":"NCT05169060","phase":"PHASE1, PHASE2","title":"Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy","status":"RECRUITING","sponsor":"University of Iowa","startDate":"2023-06-12","conditions":"Diabetic Neuropathies","enrollment":100},{"nctId":"NCT07067515","phase":"PHASE1, PHASE2","title":"Effectiveness of Omega-3 Poly Unsaturated Fatty Acids on The Treatment of Gingival Hyperpigmentation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suez Canal University","startDate":"2024-01-03","conditions":"Hyperpigmentation, Gingival Hyperpigmentaion","enrollment":30},{"nctId":"NCT06125782","phase":"PHASE2","title":"Effect of Omega-3 Fatty Acid on Neurobehavioral Status of Children With Autism Spectrum Disorder: A Randomized, Double-Blind, Placebo Controlled Trial","status":"COMPLETED","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2023-09-19","conditions":"Autism Spectrum Disorder","enrollment":64},{"nctId":"NCT07054762","phase":"NA","title":"Effects of Omega-3 Supplementation on Exercise Performance, Body Composition, and Appetite Status in Female Athletes","status":"COMPLETED","sponsor":"Betul Uner","startDate":"2025-01-10","conditions":"Volleyball Players","enrollment":14},{"nctId":"NCT07050524","phase":"PHASE2","title":"Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II Trial","status":"NOT_YET_RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2025-09-01","conditions":"Gastric Cancer Stage III","enrollment":80},{"nctId":"NCT03831178","phase":"PHASE2","title":"Docosahexaenoic Acid (DHA) for Women With Breast Cancer in the Neoadjuvant Setting","status":"ACTIVE_NOT_RECRUITING","sponsor":"AHS Cancer Control Alberta","startDate":"2019-08-28","conditions":"Breast Cancer","enrollment":76},{"nctId":"NCT02986672","phase":"NA","title":"Intervention With Omega-3 in Children With Attention Deficit Hyperactivity Disorder(ADHD)","status":"COMPLETED","sponsor":"University Hospital of North Norway","startDate":"2017-11-03","conditions":"ADHD, ADD","enrollment":332},{"nctId":"NCT06992726","phase":"PHASE4","title":"Improvement of Fish Oil in Obesity With Mild Cognitive Impairment","status":"NOT_YET_RECRUITING","sponsor":"Weiwei Ma","startDate":"2025-08-01","conditions":"Obesity, Mild Cognitive Impairment","enrollment":88},{"nctId":"NCT06881966","phase":"NA","title":"The Effect of Omega-3 Fatty Acids in Patients With Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Hopital Charles Nicolle","startDate":"2025-09-01","conditions":"Rheumatoid Arthritis (RA)","enrollment":180},{"nctId":"NCT03757585","phase":"PHASE4","title":"Natural Treatments for the Management of Emotional Dysregulation in Youth With Non-verbal Learning Disability (NVLD) and/or Autism Spectrum Disorders (ASD)","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2019-05-20","conditions":"Non-verbal Learning Disorder, Autism Spectrum Disorder, Autism","enrollment":54},{"nctId":"NCT06992323","phase":"NA","title":"Cardiometabolic Properties of Omega-3 Functionalized With Hydroxytyrosol","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Research Council, Spain","startDate":"2025-02-17","conditions":"Hypertriglyceridemia, Normal","enrollment":68},{"nctId":"NCT04222660","phase":"NA","title":"Corneal Nerves Function and Structure","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2021-06-21","conditions":"Diabetic Peripheral Neuropathy","enrollment":44},{"nctId":"NCT06665464","phase":"NA","title":"Bioavailability of Omega-3 Fatty Acids From Fish Oil Supplements","status":"COMPLETED","sponsor":"Wageningen University and Research","startDate":"2024-11-20","conditions":"Nutrition, Absorption, Metabolism and Excretion in Healthy Volunteers, Fish Oils","enrollment":12},{"nctId":"NCT02647723","phase":"NA","title":"Improving Maternal and Child Health Through Prenatal Fatty Acid Supplementation","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Chicago","startDate":"2016-01","conditions":"Pregnancy, Child Development","enrollment":168},{"nctId":"NCT03428477","phase":"PHASE3","title":"EPA for Metastasis Trial 2","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mark A Hull, PhD FRCP","startDate":"2018-05-02","conditions":"Liver Metastasis, Colon Cancer","enrollment":418},{"nctId":"NCT00798226","phase":"PHASE1","title":"Fish Oil Supplementation During Pregnancy for Prevention of Asthma, Eczema and Allergies in Childhood","status":"ACTIVE_NOT_RECRUITING","sponsor":"Copenhagen Studies on Asthma in Childhood","startDate":"2008-11-26","conditions":"Asthma, Eczema, Allergy","enrollment":800},{"nctId":"NCT06918080","phase":"PHASE4","title":"Hepatoprotective Measures for Children at High Risk of NAFLD","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ain Shams University","startDate":"2023-11-19","conditions":"Non Alcoholic Fatty Liver Diseases (NAFLD), Obesity and Overweight, Acute Lymphoblastic Leukemia","enrollment":200},{"nctId":"NCT05822141","phase":"NA","title":"Omega-3 Fatty Acids as Regulators of Brown Adipose Tissue During Cold Exposure","status":"RECRUITING","sponsor":"Indiana University","startDate":"2023-06-12","conditions":"Cold Exposure","enrollment":30},{"nctId":"NCT05573672","phase":"PHASE2","title":"Dietary Counselling Plus Omega-3 Supplementation in the Treatment of Generalized Anxiety Disorder","status":"COMPLETED","sponsor":"The Canadian College of Naturopathic Medicine","startDate":"2022-08-12","conditions":"Generalized Anxiety Disorder","enrollment":50},{"nctId":"NCT03018041","phase":"PHASE3","title":"The Long-term Effect of Marine Omega-3 Fatty Acid Supplementation in Renal Transplantation","status":"COMPLETED","sponsor":"Joe Chan","startDate":"2017-09-01","conditions":"Kidney Transplantation","enrollment":174},{"nctId":"NCT01248130","phase":"PHASE2","title":"Omega-3 Fatty Acids Monotherapy in Children and Adolescents With Autism Spectrum Disorders","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2009-11","conditions":"Autism Spectrum Disorder (ASD)","enrollment":7},{"nctId":"NCT06154408","phase":"NA","title":"Evaluating the Impact of Omega-3 Fatty Acid Supplementation (Soloways™) on Lipid Profiles in Adults With PPARG Polymorphisms","status":"COMPLETED","sponsor":"S.LAB (SOLOWAYS)","startDate":"2022-02-10","conditions":"LDL Hyperlipoproteinemia, Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia, Triglyceride Storage Type I or II Disease","enrollment":102},{"nctId":"NCT03216057","phase":"NA","title":"Effect of Omega-3 Fatty Acids Supplementation on Hypertriglyceridemia in Pediatric Patients With Obesity.","status":"COMPLETED","sponsor":"Hospital Infantil de Mexico Federico Gomez","startDate":"2008-05-20","conditions":"Hypertriglyceridemia, Pediatric Obesity","enrollment":168},{"nctId":"NCT03313076","phase":"PHASE2","title":"Vitamin D and n-3 Polyunsaturated Fatty Acids (PUFAs) to Prevent Chronic Pain Following Major Thermal Burn Injury","status":"TERMINATED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2018-07-19","conditions":"Chronic Pain Following Thermal Burn Injury","enrollment":24},{"nctId":"NCT04163328","phase":"PHASE4","title":"Effects of Supplementation With PUFAs and Antioxidants for Contact Lens Discomfort","status":"TERMINATED","sponsor":"University of Alabama at Birmingham","startDate":"2022-09-16","conditions":"Dry Eye, Contact Lens Complication","enrollment":31},{"nctId":"NCT06736925","phase":"NA","title":"Omega-3 Fatty Acids and Subconcussive Head Impacts","status":"RECRUITING","sponsor":"Indiana University","startDate":"2025-02-28","conditions":"Subconcussive Head Impact, Omega-3 Fatty Acids","enrollment":208},{"nctId":"NCT04116203","phase":"PHASE1","title":"Dietary Fish Oil Intervention in Polycystic Ovary Syndrome (PCOS)","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2016-06-30","conditions":"Polycystic Ovary Syndrome, Lipid Metabolism Disorders","enrollment":52},{"nctId":"NCT02371460","phase":"PHASE3","title":"Maternal Omega-3 Supplementation to Reduce Bronchopulmonary Dysplasia","status":"ACTIVE_NOT_RECRUITING","sponsor":"CHU de Quebec-Universite Laval","startDate":"2015-06-23","conditions":"Bronchopulmonary Dysplasia, Child Development, Neonatal and Perinatal Conditions","enrollment":800},{"nctId":"NCT06840964","phase":"NA","title":"Effect of Omega 3 in Hypertensive Patients","status":"COMPLETED","sponsor":"Santa Maria de la Salud, Argentina","startDate":"2023-03-23","conditions":"Hypertension, Dyslipidemia","enrollment":100},{"nctId":"NCT02176902","phase":"NA","title":"Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2014-11-01","conditions":"Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage IIA Prostate Cancer","enrollment":107},{"nctId":"NCT01728571","phase":"NA","title":"LungVITamin D and OmegA-3 Trial (lungVITAL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2010-07","conditions":"COPD, Asthma, Pulmonary Function","enrollment":25871},{"nctId":"NCT06172335","phase":"NA","title":"Effects of Cetoleic Acid on Atherosclerosis (Ketolinsyre's Effekt på Aterosklerose)","status":"RECRUITING","sponsor":"Oslo University Hospital","startDate":"2024-01-03","conditions":"Metabolic Syndrome","enrollment":70},{"nctId":"NCT06150261","phase":"NA","title":"Effects of an Omega-3 Fatty Acid-based Supplement on Healthy Ageing","status":"RECRUITING","sponsor":"Helse Stavanger HF","startDate":"2023-12-08","conditions":"Healthy Aging, Ageing Well","enrollment":100},{"nctId":"NCT06492694","phase":"NA","title":"Omega-3 Supplement and Health Markers","status":"COMPLETED","sponsor":"dōTERRA International","startDate":"2024-06-10","conditions":"Healthy","enrollment":55},{"nctId":"NCT06720662","phase":"NA","title":"Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease.","status":"NOT_YET_RECRUITING","sponsor":"University of Sao Paulo","startDate":"2025-04-01","conditions":"Atherosclerosis Cardiovascular Disease","enrollment":294},{"nctId":"NCT06698588","phase":"NA","title":"Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms","status":"RECRUITING","sponsor":"Swansea University","startDate":"2024-11-07","conditions":"Sleep, Autism or Autistic Traits, ADHD or ADHD Traits","enrollment":200}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"TOOTH LOSS"}],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["purified fish oil","omega-3 fatty acids","eicosapentoenoic acid (EPA)","docosahexaenoic acid (DHA)"],"phase":"marketed","status":"active","brandName":"Omega-3 fatty acid capsules","genericName":"Omega-3 fatty acid capsules","companyName":"Medical Center Alkmaar","companyId":"medical-center-alkmaar","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Omega-3 fatty acids reduce triglycerides and modulate inflammatory pathways to support cardiovascular and metabolic health. Used for Hypertriglyceridemia, Cardiovascular disease prevention, Inflammatory conditions.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}